Management tracks: PhRMA, Arcus, Beam, Stealth, Bolt, Athenex, Click, Melinta, Kallyope and Genor

PhRMA said that Giovanni Caforio, who was chairman-elect, will become chairman of PhRMA's board. Caforio is chairman and CEO of Bristol-Myers Squibb Co. (NYSE:BMY) and succeeds Olivier Brandicourt, who stepped down as CEO of Sanofi (Euronext:SAN; NASDAQ:SNY) on September 1.

Arcus Biosciences Inc. (NYSE:RCUS) said Rekha Hemrajani will step down as COO and CFO, effective September 30. The cancer immunotherapy company said it does not plan to find a successor. Arcus promoted VP of finance Jason Barker to principal financial officer and principal accounting officer...